Download full-text PDF |
Source |
---|
BMC Womens Health
December 2024
Department of Obstetrics and Gynecology, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.
Introduction: IUDs are effective, reversible and safe methods of contraception. The mechanism of action of IUDs as a group is inducing endometrial atrophy, apoptosis, altering tubal motility; preventing sperm permeability, fertilization, and implantation. Complications of IUD include menstrual disturbance, pelvic pain, and increased risk of ectopic pregnancy with contraceptive failure, device expulsion, uterine perforation or transmural migration with misplacement of the device.
View Article and Find Full Text PDFContraception
November 2024
Department of Obstetrics and Gynecology, University of Utah School of Medicine, Salt Lake City, UT, USA. Electronic address:
Objectives: This study aimed to assess 3-year efficacy, safety, and tolerability of the Cu 175 mm intrauterine device (IUD).
Study Design: This single-arm trial recruited participants at risk of pregnancy aged 17 to 45 years at 42 U.S.
Int J Surg Case Rep
November 2024
Department of Otolaryngology-Head and Neck Surgery, St. Paul's Hospital Millennium Medical College, Addis Ababa, Ethiopia.
BMC Womens Health
October 2024
West China Second University Hospital, Sichuan University, Key Laboratory of Birth Defects and Related Diseases of Women and Children Sichuan University, Ministry of Education, Chengdu, Sichuan Province, China.
Background: This study aimed to investigate the safety and efficacy of suture fixation of the levonorgestrel-releasing intrauterine device (LNG-IUD) by hysteroscope for the treatment of adenomyosis in patients at high risk of device expulsion, to provide a viable treatment option for these patients.
Methods: Twenty-one patients with large symptomatic adenomyosis were sewed and fixed with the LNG-IUD in the uterus by hysteroscopy to prevent the device expulsion.
Results: In this prospective case series, all 21 patients were successfully sewed and fixed with the LNG-IUD in the uterus by hysteroscopy.
Eur J Contracept Reprod Health Care
December 2024
Department of Obstetrics and Gynaecology, University of Campinas (UNICAMP), Faculty of Medical Sciences, Campinas, SP, Brazil.
Objectives: To evaluate improvements in laboratory markers of anaemia (haemoglobin, haematocrit, serum iron, and ferritin) in women with subjective heavy menstrual bleeding (HMB) treated with the levonorgestrel 19.5-mg intrauterine device.
Materials And Methods: We conducted a pilot study at the Department of Obstetrics and Gynaecology, University of Campinas, Faculty of Medical Sciences, Campinas, SP, Brazil.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!